IRadimed Corporation Statistics
Share Statistics
IRadimed Corporation has 12.67M shares outstanding. The number of shares has increased by 0.08% in one year.
| Shares Outstanding | 12.67M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.03% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 7.99M |
| Failed to Deliver (FTD) Shares | 113 |
| FTD / Avg. Volume | 0.28% |
Short Selling Information
The latest short interest is 104.95K, so 0.83% of the outstanding shares have been sold short.
| Short Interest | 104.95K |
| Short % of Shares Out | 0.83% |
| Short % of Float | 1.31% |
| Short Ratio (days to cover) | 2.33 |
Valuation Ratios
The PE ratio is 34.8 and the forward PE ratio is 32.54. IRadimed Corporation's PEG ratio is 0.6.
| PE Ratio | 34.8 |
| Forward PE | 32.54 |
| PS Ratio | 9.13 |
| Forward PS | 7.4 |
| PB Ratio | 8.38 |
| P/FCF Ratio | 109.62 |
| PEG Ratio | 0.6 |
Enterprise Valuation
IRadimed Corporation has an Enterprise Value (EV) of 550.54M.
| EV / Earnings | 32.02 |
| EV / Sales | 8.4 |
| EV / EBITDA | 26.47 |
| EV / EBIT | 27.48 |
| EV / FCF | 100.87 |
Financial Position
The company has a current ratio of 4.65, with a Debt / Equity ratio of 0.
| Current Ratio | 4.65 |
| Quick Ratio | 3.87 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is 0.24% and return on capital (ROIC) is 21.57%.
| Return on Equity (ROE) | 0.24% |
| Return on Assets (ROA) | 0.19% |
| Return on Capital (ROIC) | 21.57% |
| Revenue Per Employee | 442.99K |
| Profits Per Employee | 116.17K |
| Employee Count | 148 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 1.2 |
Taxes
| Income Tax | 4.55M |
| Effective Tax Rate | 0.21 |
Stock Price Statistics
The stock price has increased by 28.35% in the last 52 weeks. The beta is 0.8, so IRadimed Corporation's price volatility has been higher than the market average.
| Beta | 0.8 |
| 52-Week Price Change | 28.35% |
| 50-Day Moving Average | 54.17 |
| 200-Day Moving Average | 47.48 |
| Relative Strength Index (RSI) | 63.12 |
| Average Volume (20 Days) | 40.05K |
Income Statement
In the last 12 months, IRadimed Corporation had revenue of 65.56M and earned 17.19M in profits. Earnings per share was 1.36.
| Revenue | 65.56M |
| Gross Profit | 50.16M |
| Operating Income | 20.04M |
| Net Income | 17.19M |
| EBITDA | 20.80M |
| EBIT | 20.04M |
| Earnings Per Share (EPS) | 1.36 |
Balance Sheet
The company has 49.76M in cash and 2.04M in debt, giving a net cash position of 47.72M.
| Cash & Cash Equivalents | 49.76M |
| Total Debt | 2.04M |
| Net Cash | 47.72M |
| Retained Earnings | 43.26M |
| Total Assets | 94.25M |
| Working Capital | 66.22M |
Cash Flow
In the last 12 months, operating cash flow was 13.47M and capital expenditures -8.01M, giving a free cash flow of 5.46M.
| Operating Cash Flow | 13.47M |
| Capital Expenditures | -8.01M |
| Free Cash Flow | 5.46M |
| FCF Per Share | 0.43 |
Margins
Gross margin is 76.5%, with operating and profit margins of 30.56% and 26.22%.
| Gross Margin | 76.5% |
| Operating Margin | 30.56% |
| Pretax Margin | 33.16% |
| Profit Margin | 26.22% |
| EBITDA Margin | 31.73% |
| EBIT Margin | 30.56% |
| FCF Margin | 8.32% |
Dividends & Yields
IRMD pays an annual dividend of $0.3, which amounts to a dividend yield of 0.53%.
| Dividend Per Share | $0.30 |
| Dividend Yield | 0.53% |
| Dividend Growth (YoY) | -76.19% |
| Payout Ratio | 20.55% |
| Earnings Yield | 2.37% |
| FCF Yield | 0.75% |
Analyst Forecast
The average price target for IRMD is $60, which is 4.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $60 |
| Price Target Difference | 4.4% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 42.89 |
| Piotroski F-Score | 7 |